We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Cost-effectiveness of maintenance rituximab treatment after second line therapy in patients with follicular lymphoma in Sweden.
- Authors
Kasteng, Frida; Erlanson, Martin; Hagberg, Hans; Kimby, Eva; Relander, Thomas; Lundkvist, Jonas
- Abstract
Rituximab has significantly improved the prognosis for patients with both indolent and aggressive non-Hodgkin's lymphoma. An economic evaluation was carried out to assess the cost-effectiveness in Sweden of rituximab as maintenance therapy for patients with follicular lymphoma in remission after second line therapy.
- Publication
Acta oncologica (Stockholm, Sweden), 2008, Vol 47, Issue 6, p1029
- ISSN
1651-226X
- Publication type
Journal Article
- DOI
10.1080/02841860802120028